Côrte-Real, L.; Brás, A.R.; Pilon, A.; Mendes, N.; Ribeiro, A.S.; Martins, T.D.; Farinha, J.P.S.; Oliveira, M.C.; Gärtner, F.; Garcia, M.H.;
et al. Biotinylated Polymer-Ruthenium Conjugates: In Vitro and In Vivo Studies in a Triple-Negative Breast Cancer Model. Pharmaceutics 2022, 14, 1388.
https://doi.org/10.3390/pharmaceutics14071388
AMA Style
Côrte-Real L, Brás AR, Pilon A, Mendes N, Ribeiro AS, Martins TD, Farinha JPS, Oliveira MC, Gärtner F, Garcia MH,
et al. Biotinylated Polymer-Ruthenium Conjugates: In Vitro and In Vivo Studies in a Triple-Negative Breast Cancer Model. Pharmaceutics. 2022; 14(7):1388.
https://doi.org/10.3390/pharmaceutics14071388
Chicago/Turabian Style
Côrte-Real, Leonor, Ana Rita Brás, Adhan Pilon, Nuno Mendes, Ana Sofia Ribeiro, Tiago D. Martins, José Paulo S. Farinha, M. Conceição Oliveira, Fátima Gärtner, M. Helena Garcia,
and et al. 2022. "Biotinylated Polymer-Ruthenium Conjugates: In Vitro and In Vivo Studies in a Triple-Negative Breast Cancer Model" Pharmaceutics 14, no. 7: 1388.
https://doi.org/10.3390/pharmaceutics14071388
APA Style
Côrte-Real, L., Brás, A. R., Pilon, A., Mendes, N., Ribeiro, A. S., Martins, T. D., Farinha, J. P. S., Oliveira, M. C., Gärtner, F., Garcia, M. H., Preto, A., & Valente, A.
(2022). Biotinylated Polymer-Ruthenium Conjugates: In Vitro and In Vivo Studies in a Triple-Negative Breast Cancer Model. Pharmaceutics, 14(7), 1388.
https://doi.org/10.3390/pharmaceutics14071388